NCT04577599Recruiting
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
Lung B.A.S.E.S 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Assessing Incidence and Stage of Lung Cancer Diagnosis in Subjects Ages 40-54 With a 30 Pack Year History or More Within North and South Carolina
Source: ClinicalTrials.gov · Last updated 13 Jul 2026
Brief summary (registry, in English)
Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1160 (estimated)
- First submitted
- 30 Sept 2020
- Start date
- 7 Jan 2021
- Primary completion date
- Oct 2028
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Lung cancer
- NCT number
- NCT04577599
What you commit to
- Study type: Interventional
- Planned participants: 1160
- From 7 Jan 2021 to the primary completion date, Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects meeting any of the criteria below may not participate in the study:
- Known diagnosis of lung cancer in the past 5 years.
- Any known contraindication to having a low-dose CT Scan.
- Known pregnancy.
Who the study is looking for
- Subject must meet all the following applicable inclusion criteria to participate in this study:
- Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.
- Age 40-54 years at the time of consent.
- A positive smoking history of greater/equal to 30 pack years and they are either currently smoking or have quit within the last 15 years.
- Ability to read and understand the English and/or Spanish language.
- Ability to understand and comply with study procedures for the entire length of the study.
Age in the registry: 40 years to 54 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Levine Cancer Institute Coordinator of this site? Confirm its status | Charlotte | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.